News

The decision by Mr Justice Birss in the Patents Court in the case of Teva UK Limited and Teva Pharmaceuticals Limited (Teva) v Leo Pharma A/S and Leo Laboratories Limited (Leo) (See here), relates to a combination treatment for psoriasis and provides an interesting commentary on the assessment of obviousness and common general knowledge in […]

The Advocate General (AG) of the Court of Justice of the European Union (CJEU), Yves Bot, has issued a stern rebuke to Spain’s legal challenges to the European Unitary Patent and Unified Patent Court, and calls for their dismissal by the Court, thus providing a good indication that the final obstacles in the way of […]

The US Supreme Court’s decision in Limelight v Akamai apparently confirms that in the US, induced infringement of a patent can only occur if the patent has been directly infringed. Akamai Technologies Inc. was the exclusive licensee of a patent for a content delivery network (CDN) process. Limelight Networks Inc. was also operating a CDN. […]

1 October 2014 sees the introduction of a number of changes to design and copyright law as the Intellectual Property Act 2014 comes into force. The most noteworthy of these changes is the introduction of criminal sanctions for copying registered designs, to deter flagrant copying. Also of particular importance is the change to the provisions […]

In good news for the agrochemical industry, the Court of Justice of the European Union (CJEU) has ruled that agrochemical safeners are eligible for Supplementary Protection Certificates (SPCs). Regulatory authorisation is required before certain products, such as pharmaceuticals and agrochemicals, can be launched on the market. Authorisation can take several years, and so may significantly […]